Synpromics raises GBP5.2m of new investment
Synpromics, a synthetic promoter and gene control company, has completed a financing round of GBP5.2 million led by existing investors Calculus Capital, the Scottish Investment Bank, the investment arm of Scottish Enterprise and private shareholders. Synpromics has grown rapidly over the past two years as it expanded its portfolio of